AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

283 hedge funds and large institutions have $3.9B invested in Amedisys in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

44% less call options, than puts

Call options by funds: $23.8M | Put options by funds: $42.2M

Holders
283
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$23.8M
Puts
$42.2M
Net Calls
Net Calls Change

Top Buyers

1 +$84.6M
2 +$71.2M
3 +$27.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.6M
5
BlackRock
BlackRock
New York
+$16.9M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$1.07M
152
$1.05M
153
$1.05M
154
$1.01M
155
$966K
156
$942K
157
$918K
158
$910K
159
$909K
160
$884K
161
$884K
162
$851K
163
$819K
164
$811K
165
$801K
166
$797K
167
$787K
168
$786K
169
$773K
170
$761K
171
$749K
172
$747K
173
$742K
174
$727K
175
$724K